| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
thrombomodulin | 0.457 | 0.769 | 5.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2016 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.040 | None | 0.750 | 4 | 1 | 1998 | 2013 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
spectrin alpha, non-erythrocytic 1 | 0.601 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
TIMP metallopeptidase inhibitor 2 | 0.425 | 0.846 | 0.79 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2014 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2018 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
SIX homeobox 3 | 0.560 | 0.692 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
TGFB induced factor homeobox 1 | 0.588 | 0.769 | 1.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2006 | 2006 | ||||||||
|
TIMP metallopeptidase inhibitor 4 | 0.559 | 0.769 | 3.8E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.390 | None | 1.000 | 9 | 2 | 2009 | 2018 | ||||||||
|
monocyte to macrophage differentiation associated | 0.647 | 0.577 | 1.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.030 | None | 0.667 | 3 | 1 | 2010 | 2015 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2010 | 2013 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ring finger protein 213 | 0.628 | 0.538 | 4.9E-55 |
|
disease | 0.500 | None | 0.962 | 80 | 7 | 2011 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2017 | ||||||||
|
RNF213 antisense RNA 1 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2011 | 2011 | |||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
Malignant mesothelioma, susceptibility to | 0.792 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |